Search Results 1191-1200 of 15498 for alt

1. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

   ALT ≤ 3 x ULN; Absolute neutrophil count ≥ 1000/uL; Platelet ≥ 75000/uL; Hemoglobin ≥ 8.0 g/dL; Untreated symptomatic myeloma: Prior non-systemic therapy ...

2. Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies - Mayo Clinic

   Have abnormal liver function tests defined as ALT or AST > five times ULN. Have a positive test for human immunodeficiency virus (HIV) antibodies. Are an ...

3. A Study to Evaluate Combination Therapy to Treat Newly-diagnosed Diffuse Anaplastic Wilms Tumors and Relapsed Favorable Histology Wilms Tumors A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT - Mayo Clinic

   Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) or serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) ...

4. Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome - Mayo Clinic

   Alanine transaminase (ALT) >2 times the upper limit of normal; Serum sodium of < 125 milliequivalent/dL (mEq/dL) or > 160 mEq/dL; Serum potassium of < 3.0 mEq ...

5. Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year - Mayo Clinic

   History of significant liver disease defined by bilirubin > 2 times the upper limit of normal (ULN) or ALT or AST > 3 times the ULN on repeat testing; Poorly ...

6. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

   Alanine aminotransferase (ALT) ≤ 3×ULN;; Aspartate aminotransferase (AST) ≤ 3×ULN;; Total bilirubin < 2.0 mg/dL (or < 3.0 mg/dL for subjects with documented ...

7. A Study to Evaluate Estetrol to Treat Moderate-to-Severe Vasomotor Symptoms in Postmenopausal Women - Mayo Clinic

   ... (ALT) or aspartate transaminase (AST) > 2 x upper limit of normal (ULN), bilirubin > 1.5 ULN]; 15. Chronic or current acute renal impairment (estimated ...

8. A Study to Evaluate the Feasibility of Memantine in Reducing Cognitive Impairment in Pediatric Patients After Radiation Therapy for Central Nervous System Tumors - Mayo Clinic

   ... (ALT) ≤ 2.5 x ULN. Provide informed consent if over age 18, or provide assent with consent from parent or legal guardian if age 7-17. Negative pregnancy ...

9. MC230813 A Study of Golcadomide with Rituximab prior to CAR-T with Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate transaminase (AST); ≤2.5 x ULN (≤5 x ULN if there is evidence of parenchymal liver involvement with lymphoma) ...

10. A Study to Evaluate Ulixertinib to Treat Patients with Advanced Malignancies Harboring MEK or Atypical BRAF Alterations - Mayo Clinic

    Adequate hepatic function [total bilirubin ≤ 1.5 times ULN; AST (aspartate transaminase) and ALT (alanine transaminase) ≤ 3 times ULN or ≤ 5 times ULN if ...